Recent research shows that up to 18% of the general population worldwide suffer from FI.1 However, due to the shame and emotional toll of this condition - many people avoid seeking treatment, and the number of cases is likely higher.2
Solesta is an injectable outpatient product for the treatment of fecal incontinence in patients 18 years and older who have failed conservative therapy (e.g. diet, fiber therapy, antimotility medications, pelvic floor exercises (Kegels), biofeedback).
K. Ng, Y. Sivakumaran, N. Nassar, M. A. Gladman. Fecal incontinence: community prevalence and associated factors–a systematic review. Dis Colon Rectum. 2015;58(12):1194-1209.
Irwin T, Snow AR, Orton TS, Elliot C. Endoscopic, ultrasonographic, and histologic descriptions of dextranomer/hyaluronic acid in a case of fecal incontinence. Case Reports in Pathology. 2018.